Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E
about
Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Complement Evasion Strategies of Viruses: An Overview.The resistance of retroviral vectors produced from human cells to serum inactivation in vivo and in vitro is primate species dependent.Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzeesSpontaneous regression of Friend virus-induced erythroleukemia. VI. Structural and antigenic differences between the regressing and conventional strains of virusDisassembly of viral membranes by complement independent of channel formationRole and significance of the complement system in mucosal immunity: particular reference to the human breast milk complement.Mapping the interactions of dengue virus NS1 protein with human liver proteins using a yeast two-hybrid system: identification of C1q as an interacting partner.Retrovirus-induced feline pure red cell aplasia. Hematopoietic progenitors are infected with feline leukemia virus and erythroid burst-forming cells are uniquely sensitive to heterologous complementAntibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59Neutralizing antibody response of rabbits and goats to caprine arthritis-encephalitis virus.Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.Inhibitors of retrovirus infection are secreted by several hamster cell lines and are also present in hamster seraNeutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis.Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation.The complement system: its importance in the host response to viral infection.Virolysis of mouse mammary tumor virus by sera from breast cancer patients.Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus.Rosettes from Friend leukemia virus envelope: preparation and physicochemical and partial biological characterization.Evaluation of the Galalpha1-3Gal epitope as a host modification factor eliciting natural humoral immunity to enveloped viruses.Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.Complement and the host's defense against the pneumococcus.Envelope polypeptides of Friend leukemia virus: purification and structural analysis.Human serum-resistant retroviral vector particles from galactosyl (alpha1-3) galactosyl containing nonprimate cell lines.Complement and anti-alpha-galactosyl natural antibody-mediated inactivation of murine retrovirus occurs in adult serum but not in umbilical cord serum.Human T-cell leukaemia virus is not lysed by human serum.Studies of the binding of human and guinea pig C1 to human and guinea pig lymphocytes.
P2860
Q24675546-1255C02A-85F4-4D1D-ADD3-339C5C236008Q33804431-CCE1F670-853E-43EB-B46F-0B981020D1CBQ33817487-6873722C-BB95-489C-92B3-2633B65A1384Q33864057-4CF8591D-93FA-48E6-BD7D-A692B0B9453FQ33916201-087A88D7-0CB1-4E9C-AE1F-36706749FEFCQ33981914-C8616F65-9BAE-45D0-83BC-E36B8C74122DQ34135699-4EA2131B-E416-4503-BDBB-5E3EEB7581F7Q34629343-838A6FAA-878F-4D37-8704-C0B146A37A9FQ35580131-5B1B5EE2-19A9-42E1-B525-180EC076FFE9Q35763321-8F4A21B3-5A39-40E0-AD9A-99C9BEAB2E6FQ36336883-F9BBFE1A-49B3-42E5-A7DF-5EDEC2326F4CQ36365174-0C9DCF44-4210-45FC-988C-6EFA306CEC29Q36365516-BE96F4E4-436C-4671-BE5B-99176344B363Q36651916-0A86C436-BC1D-4947-B6B2-605AEE8E4AE3Q36795915-DE1D257B-2C42-4C20-921F-2268E8049704Q36876002-8D661F3C-E8CB-4F18-9A29-3076BB56EF48Q37066281-96215924-6921-4B24-A72F-2A558075DE66Q37334319-A97B70FE-22FB-45F6-A272-B9AAACC74A93Q38646953-CBEE73D0-3C05-4EF9-8607-39FE39B96CCFQ39538645-8A663DD6-1E0F-40DB-9AA8-EF4F616F42CCQ39580367-B820E833-F3D1-418D-9A6A-CDEA67AF4E78Q40042967-2A5FAC7A-605A-4F6D-8560-F34A06650975Q40196503-251FAFF6-537F-4305-B21B-C29748760094Q40306548-E85FF3E2-E969-4787-BCBB-F049E18FC5BEQ40931998-2B2F5950-4DED-4B73-9014-2C47728D9E31Q40952196-291F851D-80B5-4C67-BF9C-F4E148616AE9Q45804305-B4C1C52B-60BA-4808-B943-BD0F395AD217Q53964850-04217C1E-2A2F-472E-8843-0166E80F916C
P2860
Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@ast
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@en
type
label
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@ast
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@en
prefLabel
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@ast
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@en
P2093
P2860
P356
P1476
Lysis of oncornaviruses by hum ...... tor and identification as p15E
@en
P2093
Bartholomew RM
Müller-Eberhard HJ
P2860
P304
P356
10.1084/JEM.147.3.844
P407
P577
1978-03-01T00:00:00Z